申请人:SMITHKLINE BECKMAN CORPORATION
公开号:EP0191621A2
公开(公告)日:1986-08-20
Compounds of structure (II)
in which R is hydrogen or C1-4 alkyl; n is 1 to 5; and R2 to R6 are the same or different and are each hydrogen, halogen, hydroxy, CI-4 alkyl, CN, N02, S02NH2, C02H, CONH2, CHO, CH20H, CF3, C1-4alkoxy, SO2C1-4 alkoxy, SO2C1-4fluoroalkyl or CO2C1-4 alkyl, and pharmaceutically acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy as dopamine-β-hydroxylase inhibitors.
结构(II)的化合物,其中R为氢或C1-4烷基;n为1至5;R2至R6相同或不同,且各自为氢、卤素、羟基、CI-4烷基、CN、N02、S02NH2、C02H、CONH2、CHO、CH20H、CF3、C1-4烷氧基、SO2C1-4烷氧基、SO2C1-4氟烷基或CO2C1-4烷基,以及它们的药学上可接受的盐、它们的制备工艺、含有它们的药物组合物和它们作为多巴胺-β-羟化酶抑制剂在治疗中的用途。